A novel ionizable lipid nanoparticle (LNP) formulated with lipid U-101 demonstrated superior effective transfection in delivering tumor-activated Interleukin-2 (IL-2) mRNA compared with the approved LNP using ALC-0315, both in vivo and in vitro.
5 mg (N-1101)
A novel ionizable lipid nanoparticle (LNP) formulated with lipid U-101 demonstrated superior effective transfection in delivering tumor-activated Interleukin-2 (IL-2) mRNA compared with the approved LNP using ALC-0315, both in vivo and in vitro. [Read More...]
$125
